SEC Tracker
Get the app

Plus Therapeutics CNSY

Plus Therapeutics: signs a material agreement, ends a material agreement and takes on a new financial obligation

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
Exhibit 10.3
Material contract
  • Signs a material agreement (1.01)
  • Ends a material agreement (1.02)
  • Takes on a new financial obligation (2.03)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Plus Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. QT Imaging Holdings QTI public float $33M, Jun 30, 2025
  2. NutriBand NTRB
  3. Femasys FEMY public float $30M, Jun 30, 2025
  4. DarioHealth DRIO public float $28M, Jun 30, 2025
  5. HeartBeam BEAT public float $36M, Jun 30, 2025